General Articles 

General Articles

Biotech MacroGenics ramps up with funding, CEO Breaking News - Puget Sound Business Journal - September 25, 2001 "MacroGenics inc., a fledging biotech spinoff of the Seattle based Institute for Systems Biology has raised $13.5 million and hired a President and Chief executive officer."

MacroGenics - A fresh perspective on monoclonal antibodies - Nature Biotechnology. June 2001, Vol. 19 Number 6p BE12. "The beauty of monoclonal antibodies as therapeutics is that they can be generated against a limitless variety of protein targets." - By Liz Fletcher.

MacroGenics Inc. (Med.) Start-UP Jan 2001 p.22 Antibody Opportunities - "Antibodies are driving valuations at many public companies--and the aspirations of start-ups with new means of generating, tailoring and harnessing the proteins." - By Deborah Erickson.

MacroGenics Inc. (Med) Start-Up Nov 2000 p.25 Start-Up Previews (11/00) "If you were going to make an arrow, you' d think about more than the tip. You'd think about the shaft and the feathered tail and how components would influence the arrow's flight and ability to hit the target."